Skip has spent more than 20 years advising companies and not-for-profit organizations on business strategy, technology commercialization, R&D planning, and mergers and acquisitions in the medical products industry.
A pharmacist by training, Skip’s practice focuses on pharmaceuticals and biotechnology. Prior to joining Health Advances, Skip helped found seven life sciences companies as Vice President for Commercial Development at the Massachusetts Biotechnology Research Institute (MBRI). Earlier in his career, Skip founded and led the pharmaceutical consulting practice for Arthur D. Little, Inc. He has also previously worked in manufacturing and product development for AstraZeneca, and he contributed to the founding of t. Breeders, Inc., which eventually became ViaCell, Inc. and was purchased by Perkin Elmer.
While at Health Advances, Skip developed a practice advising not-for-profit disease organizations on their investments and relationships with industry including the Cystic Fibrosis Foundation, the JDRF and the Multiple Myeloma Foundation. He serves on the Board of Directors for the Michael J. Fox Foundation for Parkinson’s Research and an advisor to the Brain Tumor Society. He serves on the Board of Overseers of Mt. Auburn Hospital in Cambridge, MA and the Corporation Board of the Massachusetts College of Pharmacy and Allied Health.
Skip graduated from the Massachusetts College of Pharmacy and earned his MBA at the Amos Tuck School at Dartmouth College.
While at Health Advances Marie took a leading role in building Health Advances Connected Health Practice.
Marie brings together her 20 years of experience in commercialization planning, drug delivery and chronic disease management to provide a unique angle on how her diagnostic, medtech, and biopharma clients should be integrating commercial solutions to optimize their portfolios over time. She also advises care providers and technology solution companies on their product roadmaps based on her understanding of customer needs in key diseases, most notably diabetes. Marie brings first-hand knowledge to these clients as she took a sabbatical from Health Advances in 2010 to cofound the T1D Exchange, a first-in-class, real-world health engagement platform.
Prior to joining Health Advances in 1998, Marie worked in industry for two early-stage biotech companies, Gel Sciences and Arqule. She received a BA in chemistry from the University of Vermont.